Literature DB >> 20141541

Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis.

Inga Wessels1, Daniela Fleischer, Lothar Rink, Peter Uciechowski.   

Abstract

SUMMARY: Interleukin-1beta (IL-1beta) induces the expression of a variety of proteins responsible for acute inflammation and chronic inflammatory diseases. However, the molecular regulation of IL-1beta expression in myeloid differentiation has not been elucidated. In this study the chromatin structure of the IL-1beta promoter and the impact of methylation on IL-1beta expression in monocytic development were examined. The results revealed that the IL-1beta promoter was inaccessible in undifferentiated promyeloid HL-60 cells but highly accessible in differentiated monocytic cells which additionally acquired the ability to produce IL-1beta. Accessibilities of differentiated cells were comparable to those of primary monocytes. Lipopolysaccharide (LPS) stimulation did not affect promoter accessibility in promyeloid and monocytic HL-60 cells, demonstrating that the chromatin remodelling of the IL-1beta promoter depends on differentiation and not on the transcriptional status of the cell. Demethylation via 5-aza-2'-deoxycytodine led to the induction of IL-1beta expression in undifferentiated and differentiated cells, which could be increased after LPS stimulation. Our data indicate that the IL-1beta promoter is reorganized into an open poised conformation during monopoiesis being a privilege of mature monocytes but not of the entire myeloid lineage. As a second mechanism, IL-1beta expression is regulated by methylation acting independently of the developmental stage of myeloid cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20141541      PMCID: PMC2913220          DOI: 10.1111/j.1365-2567.2009.03243.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.

Authors:  Yutaka Kondo; LanLan Shen; Jean-Pierre J Issa
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 2.  Mechanisms of matrix degradation in rheumatoid arthritis.

Authors:  S M Krane; W Conca; M L Stephenson; E P Amento; M B Goldring
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 3.  The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression.

Authors:  S J Collins
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

4.  Differentiation-dependent modulation of TNF production by PAF in human HL-60 myeloid leukemia cells.

Authors:  M Rola-Pleszczynski; J Stankova
Journal:  J Leukoc Biol       Date:  1992-06       Impact factor: 4.962

5.  The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction.

Authors:  F Shirakawa; K Saito; C A Bonagura; D L Galson; M J Fenton; A C Webb; P E Auron
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

Review 6.  Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha.

Authors:  Alan D Friedman; Jeffrey R Keefer; Tanawan Kummalue; Huaitian Liu; Qian-fei Wang; Rebecca Cleaves
Journal:  Blood Cells Mol Dis       Date:  2003 Nov-Dec       Impact factor: 3.039

7.  Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes.

Authors:  Hajo Haase; Julia L Ober-Blöbaum; Gabriela Engelhardt; Silke Hebel; Antje Heit; Holger Heine; Lothar Rink
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 8.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

9.  Enhanced interleukin-1 production by human monocyte cell lines following treatment with 5-azacytidine.

Authors:  E J Kovacs; J J Oppenheim; D B Carter; H A Young
Journal:  J Leukoc Biol       Date:  1987-01       Impact factor: 4.962

Review 10.  The IL-1 family and inflammatory diseases.

Authors:  C A Dinarello
Journal:  Clin Exp Rheumatol       Date:  2002 Sep-Oct       Impact factor: 4.473

View more
  8 in total

Review 1.  Immune senescence, epigenetics and autoimmunity.

Authors:  Donna Ray; Raymond Yung
Journal:  Clin Immunol       Date:  2018-04-11       Impact factor: 3.969

2.  Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice.

Authors:  Tony W H Li; Heping Yang; Hui Peng; Meng Xia; José M Mato; Shelly C Lu
Journal:  Carcinogenesis       Date:  2011-12-09       Impact factor: 4.944

3.  Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation.

Authors:  Carmen P Wong; Nicole A Rinaldi; Emily Ho
Journal:  Mol Nutr Food Res       Date:  2015-03-17       Impact factor: 5.914

4.  Aging and peripheral lipopolysaccharide can modulate epigenetic regulators and decrease IL-1β promoter DNA methylation in microglia.

Authors:  Stephanie M Matt; Marcus A Lawson; Rodney W Johnson
Journal:  Neurobiol Aging       Date:  2016-07-15       Impact factor: 4.673

5.  The chromatin remodeling and mRNA splicing functions of the Brahma (SWI/SNF) complex are mediated by the SNR1/SNF5 regulatory subunit.

Authors:  Claudia B Zraly; Andrew K Dingwall
Journal:  Nucleic Acids Res       Date:  2012-03-29       Impact factor: 16.971

Review 6.  Genetic and Epigenetic Regulation of Aortic Aneurysms.

Authors:  Ha Won Kim; Brian K Stansfield
Journal:  Biomed Res Int       Date:  2017-01-01       Impact factor: 3.411

7.  Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes.

Authors:  Ewelina Wiśnik; Tomasz Płoszaj; Agnieszka Robaszkiewicz
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

Review 8.  Interleukin-1 Beta-A Friend or Foe in Malignancies?

Authors:  Rebekka Bent; Lorna Moll; Stephan Grabbe; Matthias Bros
Journal:  Int J Mol Sci       Date:  2018-07-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.